Tango Therapeutics (TNGX) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$564.4 million.
- Tango Therapeutics' Retained Earnings fell 2166.79% to -$564.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$564.4 million, marking a year-over-year decrease of 2166.79%. This contributed to the annual value of -$501.6 million for FY2024, which is 3509.76% down from last year.
- Per Tango Therapeutics' latest filing, its Retained Earnings stood at -$564.4 million for Q3 2025, which was down 2166.79% from -$580.3 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Retained Earnings ranged from a high of -$362800.0 in Q1 2021 and a low of -$580.3 million during Q2 2025
- Moreover, its 5-year median value for Retained Earnings was -$318.2 million (2023), whereas its average is -$317.5 million.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 26339740.83% in 2021, then plummeted by 2166.79% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' Retained Earnings stood at -$161.3 million in 2021, then tumbled by 67.05% to -$269.5 million in 2022, then plummeted by 37.75% to -$371.3 million in 2023, then plummeted by 35.1% to -$501.6 million in 2024, then dropped by 12.53% to -$564.4 million in 2025.
- Its Retained Earnings was -$564.4 million in Q3 2025, compared to -$580.3 million in Q2 2025 and -$541.4 million in Q1 2025.